Indian Budesonide Exporters: Complete Supplier Ranking with Market Share — 609 Manufacturers (2026) — TransData Nexus

Q: Who is the largest budesonide buyer importing from India?

CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) is the largest budesonide importer from India with a 45.4% market share and import value of $86.4M.

Q: How many budesonide buyers import from India?

There are 609 active budesonide buyers importing from India, with a combined import market of $190.5M across 9,145 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top budesonide buyers from India?

The top 5 budesonide buyers — CIPLA USA INC UPS SUPPLY CHAIN SOLU, ACINO PHARMACEUTICALS FZ LLC, BIOPHARM DISTRIBUTION SPA, CIPLA USA INC UPS SUPPLY CHAIN SOL, EXELAN PHARMACEUTICALS, INC — together control 61.0% of total budesonide import value from India.

Suresh Sormare

Budesonide

India Pharmaceutical Trade Intelligence

$190.5M275 Suppliers115 CountriesHS 30049099

ExportsIndia → UNITED STATES55.0%India → SAUDI ARABIA15.2%

ImportsITALY → India$229.2M SWEDEN → India$74.5M

#1 Supplier: CIPLA LIMITED #1 Buyer: CIPLA USA

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $104.8M through 488 shipments. This represents a market share of 55.0% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• CIPLA USA INC UPS SUPPLY CHAIN SOLU - $86.4M (82.5% of country's total business)

• CIPLA USA INC UPS SUPPLY CHAIN SOL - $4.6M (4.4% of country's total business)

• EXELAN PHARMACEUTICALS, INC - $3.9M (3.7% of country's total business)

• SUN PHARMACEUTICAL INDUSTRIES,INC. - $3.2M (3.0% of country's total business)

• SUN PHARMACEUTICAL INDUSTRIES INC - $1.5M (1.4% of country's total business)

• Rest of United States's importers - $5.2M (4.9% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $214.7K, indicating premium pricing strategy compared to the market average of $20.8K.

United States is a key market for Budesonide imports, representing 55.0% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Budesonide buyer market intelligence

1Buyer Segment Analysis

The importers of Budesonide from India can be categorized into several key segments:

1. Distributors: These entities purchase Budesonide in bulk to supply to various healthcare providers, pharmacies, and retailers. Their buying behavior typically involves large, regular orders to maintain a steady supply chain. Notable distributors among the top buyers include:

CIPLA USA INC UPS SUPPLY CHAIN SOLU (United States, $86.41M)

ACINO PHARMACEUTICALS FZ LLC (United Arab Emirates, $12.94M)

BIOPHARM DISTRIBUTION SPA (Algeria, $8.26M)

2. Contract Manufacturers: These companies procure Budesonide as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement patterns are aligned with production schedules and client demands. Examples include:

SUN PHARMACEUTICAL INDUSTRIES, INC. (United States, $3.16M)

EXELAN PHARMACEUTICALS, INC (United States, $3.92M)

Country-Specific Import Regulations

TransData Nexus Budesonide buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Budesonide from India, the import regulations are as follows:

1. United States

Drug Regulatory Authority: U.S. Food and Drug Administration (FDA)

Import Registration Process: Importers must ensure that Budesonide is approved by the FDA. This involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic drugs. Additionally, facilities involved in manufacturing, processing, or packaging must be registered with the FDA.

Estimated Timeline for Registration: The approval process can vary; NDAs may take 6-10 months, while ANDAs typically take 8-10 months.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in the United States.

2. Saudi Arabia

Drug Regulatory Authority: Saudi Food and Drug Authority (SFDA)

Demand Drivers & Market Opportunity

TransData Nexus Budesonide buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Budesonide in importing countries is driven by several factors:

1. Disease Prevalence: Budesonide is primarily used to manage respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). According to the World Health Organization (WHO), as of 2024, approximately 262 million people worldwide suffer from asthma, with a significant burden in low- and middle-income countries. The prevalence of COPD is also rising, contributing to increased demand for effective treatments like Budesonide.

2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are enhancing their healthcare systems to provide broader access to essential medicines. For instance, the Philippines has been implementing the Universal Health Care (UHC) Act since 2019, aiming to ensure equitable access to quality and affordable health services. Such initiatives often include the procurement of essential medicines like Budesonide to meet public health needs.

3. WHO Essential Medicines List Procurement and Tender-Based Purchasing: Budesonide is listed on the WHO Model List of Essential Medicines, indicating its importance in a basic health system. This inclusion encourages countries to procure Budesonide through national tenders and public procurement systems to ensure availability in public health facilities. For example, in 2023, Turkey reported challenges in the availability and affordability of essential medicines, including Budesonide, highlighting the need for effective procurement strategies. (iris.who.int)

With 609 buyers across 115 countries, the global market for Budesonide presents substantial opportunities. Understanding the specific demand drivers in each region enables targeted strategies to meet the growing need for this essential medication.

Common Questions — Budesonide Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest budesonide buyer importing from India?

Based on import volume and value, CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) leads with $86.4M in imports and a 45.4% market share — the highest of any single budesonide importer. ACINO PHARMACEUTICALS FZ LLC (UNITED ARAB EMIRATES) and BIOPHARM DISTRIBUTION SPA (ALGERIA) are the next largest buyers.

QHow many companies buy budesonide from India?

There are 609 active budesonide buyers importing from India, with a combined market of $190.5M across 9,145 shipments to 115 countries. The top 5 buyers hold 61.0% of total import value, while the remaining 604 buyers handle the other 39.0%.

QWhich countries import the most budesonide from India?

The top importing countries for budesonide from India are United States (55.0%), Saudi Arabia (15.2%), United Arab Emirates (8.0%), Algeria (6.9%), Philippines (2.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of budesonide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for budesonide from India?

The average import transaction value for budesonide from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Budesonide buyer market intelligence

1Buyer Segment Analysis

The importers of Budesonide from India can be categorized into several key segments:

CIPLA USA INC UPS SUPPLY CHAIN SOLU (United States, $86.41M)

ACINO PHARMACEUTICALS FZ LLC (United Arab Emirates, $12.94M)

BIOPHARM DISTRIBUTION SPA (Algeria, $8.26M)

SUN PHARMACEUTICAL INDUSTRIES, INC. (United States, $3.16M)

EXELAN PHARMACEUTICALS, INC (United States, $3.92M)

Country-Specific Import Regulations

TransData Nexus Budesonide buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Budesonide from India, the import regulations are as follows:

1. United States

Drug Regulatory Authority: U.S. Food and Drug Administration (FDA)

Estimated Timeline for Registration: The approval process can vary; NDAs may take 6-10 months, while ANDAs typically take 8-10 months.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in the United States.

2. Saudi Arabia

Drug Regulatory Authority: Saudi Food and Drug Authority (SFDA)

Demand Drivers & Market Opportunity

TransData Nexus Budesonide buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Budesonide in importing countries is driven by several factors:

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Budesonide

Budesonide

Who Buys Budesonide from India — 609 Importers Behind a $190.5M Market

Top Budesonide Importers — Ranked by Import Value

Top Budesonide Buyers & Importers

Related Analysis

Need Details?

Budesonide — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Budesonide — and from which countries?

Budesonide — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Budesonide Buyers & Importers

QWho is the largest budesonide buyer importing from India?

QHow many companies buy budesonide from India?

QWhich countries import the most budesonide from India?

QWhat is the average import order value for budesonide from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Saudi Arabia

3United Arab Emirates

4Algeria

5Philippines

Analysis Methodology